Mylotarg, fludarabine, cytarabine (ara-C), and cyclosporine (MFAC) regimen as post-remission therapy in acute myelogenous leukemia

Apostolia M. Tsimberidou, Elihu Estey, Jorge E. Cortes, Guillermo Garcia-Manero, Stefan Faderl, Srdan Verstovsek, Deborah A. Thomas, Alessandra Ferrajoli, Michael J. Keating, Susan O'Brien, Hagop M. Kantarjian, Francis J. Giles*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

31 Scopus citations

Fingerprint

Dive into the research topics of 'Mylotarg, fludarabine, cytarabine (ara-C), and cyclosporine (MFAC) regimen as post-remission therapy in acute myelogenous leukemia'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

INIS